2026 Annual Meeting | C193 - Rapidly Progressive Dementia
| 03:30 PM - 03:45 PM CDT | Speaker |
Introduction and Approach to RPD
Valerie Sim, MD, BSc |
| 03:45 PM - 04:15 PM CDT | Speaker |
Prion and Prion-like Causes of RPD
Valerie Sim, MD, BSc |
| 04:15 PM - 04:45 PM CDT | Speaker |
Autoimmune / Paraneoplastic Encephalitis
Jennifer McCombe, MD |
| 04:45 PM - 05:15 PM CDT | Speaker |
Case Review
Valerie Sim, MD, BSc, Jennifer McCombe, MD |
| 05:15 PM - 05:30 PM CDT | Q&A |
Questions and Answers
Valerie Sim, MD, BSc, Jennifer McCombe, MD |
| Valerie Sim, MD, BSc | The institution of Dr. Sim has received research support from CJD Foundation. The institution of Dr. Sim has received research support from National Research Council of Canada Nanotechnology Research Centre. The institution of Dr. Sim has received research support from Alberta Innovates. The institution of Dr. Sim has received research support from Alzheimer Society of Canada. The institution of Dr. Sim has received research support from ALS Canada / Brain Canada. The institution of Dr. Sim has received research support from Results Driven Agricultural Research. Dr. Sim has received intellectual property interests from a discovery or technology relating to health care. Dr. Sim has received personal compensation in the range of $500-$4,999 for serving as a Clinical neurology consultant for human prion diseases with Public Health Agency of Canada. |
| Jennifer McCombe, MD | Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics. |